USNA USANA Health Sciences, Inc. Common Stock

NYSE · Consumer products · عرض على SEC EDGAR ↗
$13,59
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 13, 2026

حول USANA Health Sciences, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

اقرأ المزيد

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its independent distributors (referred to as "associates") or by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee distributors, known as sales "associates", as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗

Wikidata ↗

USNA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا

السعر
$13.59
القيمة السوقية
$251M
P/E (TTM)
23.6
ربح السهم (آخر 12 شهرًا)
$0.58
الإيرادات (آخر 12 شهرًا)
$925M
عائد التوزيعات
ROE
2.0%
D/E الدين/حقوق الملكية
نطاق 52 أسبوعًا
$13 – $32

USNA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك

أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم

الإيرادات وصافي الدخل $925M
10-point trend, -8.0%
2016-12-31 2026-01-03
ربح السهم $0.58
10-point trend, -85.5%
2016-12-31 2026-01-03
التدفق النقدي الحر $9M
10-point trend, -91.8%
2016-12-31 2026-01-03
الهوامش 1.2%
10-point trend, -4.6%
2016-12-31 2026-01-03

التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟

المقياس
اتجاه 5 سنوات
USNA
متوسط الأقران
P/E (TTM)
5-point trend, +89.8%
23.6
15.6
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
5-point trend, -76.8%
0.3
0.6
P/B (السعر / القيمة الدفترية)
5-point trend, -86.6%
0.5
2.6
Price / FCF (السعر / التدفق النقدي الحر)
5-point trend, +130.4%
29.4

الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)

المقياس
اتجاه 5 سنوات
USNA
متوسط الأقران
Gross Margin (هامش الربح الإجمالي)
5-point trend, -4.1%
78.3%
69.1%
Operating Margin (هامش التشغيل)
5-point trend, -71.8%
4.0%
Net Profit Margin (هامش صافي الربح)
5-point trend, -88.2%
1.2%
3.9%
ROA (العائد على الأصول)
5-point trend, -92.5%
1.4%
5.0%
ROE
5-point trend, -93.1%
2.0%
9.6%
ROIC
5-point trend, -93.4%
1.9%

الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية

المقياس
اتجاه 5 سنوات
USNA
متوسط الأقران
Current Ratio (النسبة الحالية)
5-point trend, -1.2%
2.2
2.5
Quick Ratio (النسبة السريعة)
5-point trend, -17.4%
1.2

النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)

المقياس
اتجاه 5 سنوات
USNA
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
5-point trend, -22.0%
8.3%
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
5-point trend, -22.0%
-2.5%
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
5-point trend, -22.0%
-4.0%
EPS YoY (ربحية السهم على أساس سنوي)
5-point trend, -89.9%
-73.5%
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
5-point trend, -90.8%
-74.4%

مقاييس للسهم ربحية السهم (EPS)، القيمة الدفترية للسهم، التدفق النقدي للسهم، توزيعات الأرباح للسهم

المقياس
اتجاه 5 سنوات
USNA
متوسط الأقران
EPS (Diluted) (ربحية السهم (مخففة))
5-point trend, -89.9%
$0.58

كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات

المقياس
اتجاه 5 سنوات
USNA
متوسط الأقران

USNA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود

بيع 6 محللين
  • شراء قوي 0 0,0%
  • شراء 0 0,0%
  • احتفاظ 3 50,0%
  • بيع 1 16,7%
  • بيع قوي 2 33,3%

السعر المستهدف لمدة 12 شهرًا

1 محللين · 2026-08-14
السعر المستهدف الوسيط $25.00 +84,0%
السعر المستهدف المتوسط $25.00 +84,0%

سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي

متوسط المفاجأة
-0.10%
الفترة EPS Actual EPS المتوقع المفاجأة
30 يونيو، 2026 $-0.07 $0.44 -0.51%
31 مارس، 2026 $0.61 $0.45 0.16%
31 ديسمبر، 2025 $0.60 $0.42 0.18%
30 سبتمبر، 2025 $-0.15 $0.48 -0.63%
30 يونيو، 2025 $0.74 $0.55 0.19%
31 مارس، 2025 $0.73 $0.71 0.02%

مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع

الرمز القيمة السوقية P/E الإيرادات سنويًا هامش الربح الصافي ROE هامش الربح الإجمالي
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NUS 3.0 -14.3% 10.8% 22.0% 69.5%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%
FTLF 25.8 26.4%

الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي

قائمة الدخل 18
بيانات قائمة الدخل السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Cost of Revenue 12-point trend, +42.7% $201M $161M $177M $194M $218M $209M $188M $201M $179M $180M $160M $141M
Gross Profit 12-point trend, +11.5% $724M $693M $744M $805M $969M $926M $873M $989M $868M $826M $759M $650M
R&D Expense 12-point trend, +108.5% $11M $12M $11M $12M $11M $11M $10M $10M $9M $9M $6M $5M
SG&A Expense 12-point trend, +82.8% $337M $263M $257M $262M $279M $261M $268M $275M $265M $234M $209M $185M
Operating Expenses 12-point trend, +28.7% $687M $627M $651M $697M $798M $749M $727M $800M $735M $687M $617M $534M
Operating Income 12-point trend, -67.8% $37M $66M $93M $108M $170M $176M $146M $188M $133M $139M $142M $116M
Interest Expense 10-point trend, +103.1% · · $262.0K $192.0K $57.0K $507.0K $66.0K $36.0K $46.0K $444.0K $15.0K $129.0K
Interest Income 12-point trend, +383.0% $2M $11M $10M $4M $3M $3M $5M $4M $2M $1M $1M $500.0K
Other Non-op 12-point trend, +407.6% $3M $-1M $7.0K $-3M $-2M $-571.0K $-335.0K $-1M $-3.0K $-1M $-174.0K $-820.0K
Pretax Income 12-point trend, -64.1% $42M $76M $102M $109M $171M $178M $150M $192M $135M $139M $143M $116M
Income Tax 12-point trend, -23.0% $30M $34M $39M $39M $54M $53M $50M $65M $72M $39M $48M $39M
Net Income 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
EPS (Basic) 12-point trend, -80.0% $0.58 $2.20 $3.31 $3.60 $5.78 $5.89 $4.44 $5.24 $2.57 $4.14 $3.72 $2.90
EPS (Diluted) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
Shares (Basic) 12-point trend, -29.9% 18,535,000 19,103,000 19,250,000 19,254,000 20,146,000 21,156,000 22,644,000 24,105,000 24,349,000 24,185,000 25,460,000 26,443,000
Shares (Diluted) 12-point trend, -32.2% 18,574,000 19,162,000 19,345,000 19,310,000 20,343,000 21,256,000 22,818,000 24,642,000 24,708,000 25,047,000 26,355,000 27,377,000
EBITDA 12-point trend, -44.0% $70M $81M $106M $121M $183M $190M $161M $205M $149M $152M $152M $125M
الميزانية العمومية 26
بيانات الميزانية العمومية السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +42.5% $158M $182M $330M $288M $240M $312M $235M $214M $247M $176M $143M $111M
Receivables $4M · · · · · · · · · · ·
Inventory 12-point trend, +126.8% $103M $70M $61M $67M $98M $90M $69M $82M $63M $65M $66M $45M
Prepaid Expense 12-point trend, -33.1% $23M $28M $26M $29M $27M $23M $26M $33M $30M $37M $35M $35M
Other Current Assets 12-point trend, -13.7% $5M $5M $6M $7M $4M $5M $5M $7M $5M $6M $5M $6M
Current Assets 12-point trend, +51.1% $288M $279M $418M $384M $365M $425M $329M $392M $340M $278M $244M $191M
PP&E (Net) 12-point trend, +32.6% $94M $95M $100M $98M $102M $100M $95M $92M $103M $101M $88M $71M
PP&E (Gross) 10-point trend, +86.4% · · $212M $210M $211M $199M $181M $178M $177M $164M $120M $114M
Accum. Depreciation 12-point trend, +109.1% $135M $130M $129M $125M $122M $116M $105M $96M $86M $76M $71M $64M
Goodwill 12-point trend, +669.0% $138M $144M $17M $17M $18M $17M $17M $17M $17M $17M $17M $18M
Intangibles 12-point trend, +225.1% $133M $152M $30M $32M $30M $31M $30M $32M $35M $34M $38M $41M
Other Non-current Assets 12-point trend, +161.1% $62M $59M $55M $55M $58M $62M $43M $18M $21M $22M $25M $24M
Total Assets 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Accounts Payable 12-point trend, +121.9% $17M $12M $10M $11M $14M $18M $13M $10M $12M $9M $10M $8M
Accrued Liabilities 3-point trend, -2.6% $10M $14M $10M · · · · · · · · ·
Current Liabilities 12-point trend, +18.3% $129M $140M $119M $144M $161M $168M $136M $149M $141M $138M $131M $109M
Capital Leases 6-point trend, -28.8% $12M $10M $5M $8M $10M · $17M · · · · ·
Deferred Tax 12-point trend, -53.9% $5M $4M $5M $4M $7M $12M $10M $13M $14M $5M $10M $11M
Other Non-current Liabilities 12-point trend, +1981.3% $23M $18M $12M $14M $14M $19M $19M $1M $1M $1M $1M $1M
Total Liabilities 3-point trend, +15.6% $157M $162M $136M · · · · · · · · ·
Common Stock 12-point trend, +38.5% $18.0K $19.0K $19.0K $19.0K $19.0K $21.0K $22.0K $24.0K $24.0K $24.0K $25.0K $13.0K
Retained Earnings 12-point trend, +179.9% $466M $479M $445M $392M $345M $383M $306M $330M $288M $265M $215M $166M
AOCI 12-point trend, -858.8% $-16M $-23M $-14M $-13M $458.0K $-4M $-14M $-10M $-1M $-12M $-4M $2M
Stockholders' Equity 12-point trend, +131.6% $533M $532M $497M $434M $395M $442M $352M $391M $363M $325M $281M $230M
Liabilities + Equity 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Shares Outstanding 12-point trend, -27.6% 18,281,000 19,064,000 19,130,000 19,206,000 19,393,000 21,038,000 21,655,000 23,567,000 24,024,000 24,485,000 24,976,000 25,266,000
التدفق النقدي 16
بيانات التدفق النقدي السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
D&A 12-point trend, +269.6% $33M $15M $13M $13M $13M $14M $15M $17M $16M $13M $10M $9M
Stock-based Comp 12-point trend, +41.0% $14M $15M $15M $13M $14M $14M $16M $15M $15M $17M $11M $10M
Deferred Tax 12-point trend, -586.8% $-7M $-7M $-3M $-7M $-3M $-2M $-4M $607.0K $19M $-4M $-3M $-1M
Amort. of Intangibles 12-point trend, +4382.1% $19M $2M $2M $2M $1M $1M $1M $2M $1M $2M $900.0K $431.0K
Restructuring 3-point trend, +6463000.00 $6M $0 $0 · · · · · · · · ·
Other Non-cash 12-point trend, -352.1% $-28M $-3M $-18M $15M $-20M $10M $-442.0K $-7M $10M $11M $-2M $11M
Operating Cash Flow 12-point trend, -78.8% $22M $61M $71M $104M $121M $160M $127M $152M $124M $137M $111M $105M
CapEx 12-point trend, -32.3% $14M $10M $14M $10M $13M $15M $17M $11M $13M $33M $24M $20M
Investing Cash Flow 12-point trend, +37.8% $-10M $-213M $-12M $-12M $-14M $-34M $47M $-69M $-13M $-32M $-25M $-16M
Stock Repurchased 12-point trend, -80.2% $28M $9M $12M $25M $178M $57M $150M $105M $50M $65M $61M $139M
Net Stock Activity 12-point trend, +80.2% $-28M $-9M $-12M $-25M $-178M $-57M $-150M $-105M $-50M $-65M $-61M $-139M
Financing Cash Flow 12-point trend, +64.1% $-41M $10M $-14M $-30M $-181M $-59M $-152M $-105M $-50M $-65M $-49M $-113M
Net Change in Cash 12-point trend, +11.2% $-23M $-149M $42M $48M $-72M $78M $20M $-33M $72M $32M $32M $-26M
Taxes Paid 3-point trend, -12.2% $37M $40M $42M · · · · · · · · ·
Free Cash Flow 12-point trend, -89.9% $9M $51M $56M $94M $108M $145M $110M $141M $111M $104M $88M $85M
Levered FCF 10-point trend, -33.9% · · $56M $93M $108M $145M $110M $141M $111M $104M $88M $85M
الربحية 8
بيانات الربحية السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Gross Margin 12-point trend, -4.7% 78.3% 81.1% 80.8% 80.6% 81.6% 81.6% 82.3% 83.1% 82.9% 82.1% 82.6% 82.2%
Operating Margin 12-point trend, -72.4% 4.0% 7.8% 10.1% 10.8% 14.3% 15.6% 13.8% 15.8% 12.7% 13.8% 15.4% 14.7%
Net Margin 12-point trend, -88.0% 1.2% 4.9% 6.9% 6.9% 9.8% 11.0% 9.5% 10.6% 6.0% 9.9% 10.3% 9.7%
Pretax Margin 12-point trend, -69.3% 4.5% 8.9% 11.1% 10.9% 14.4% 15.7% 14.2% 16.1% 12.9% 13.8% 15.5% 14.6%
EBITDA Margin 12-point trend, -52.2% 7.6% 9.5% 11.5% 12.1% 15.4% 16.8% 15.2% 17.2% 14.2% 15.1% 16.5% 15.8%
ROA 12-point trend, -93.2% 1.4% 6.1% 10.4% 11.8% 19.1% 21.5% 18.8% 23.5% 12.6% 22.4% 24.5% 21.3%
ROE 12-point trend, -93.5% 2.0% 7.9% 13.2% 16.4% 29.3% 30.0% 30.2% 30.5% 17.2% 33.0% 37.0% 31.2%
ROIC 12-point trend, -94.2% 1.9% 6.9% 11.7% 15.8% 29.4% 28.0% 27.8% 31.7% 16.9% 30.8% 33.5% 33.4%
السيولة والملاءة 3
بيانات السيولة والملاءة السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +27.7% 2.2 2.0 3.5 2.7 2.3 2.5 2.4 2.6 2.4 2.0 1.9 1.8
Quick Ratio 12-point trend, +20.5% 1.2 1.3 2.8 2.0 1.5 1.9 1.7 1.4 1.8 1.3 1.1 1.0
Interest Coverage 10-point trend, -60.5% · · 355.2 560.5 2985.8 348.1 2215.0 5232.0 2880.5 312.2 9444.1 900.0
الكفاءة 2
بيانات الكفاءة السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, -43.6% 1.2 1.2 1.5 1.7 1.9 2.0 2.0 2.2 2.1 2.3 2.4 2.2
Inventory Turnover 12-point trend, -23.4% 2.3 2.5 2.7 2.3 2.3 2.2 2.5 2.8 2.8 2.8 2.9 3.0
لكل سهم 5
بيانات لكل سهم السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +60.1% $29.16 $27.91 $25.99 $22.62 $20.37 $20.99 $16.24 $16.60 $15.12 $13.29 $22.49 $18.22
Revenue / Share 12-point trend, -13.7% $49.81 $44.59 $47.61 $51.71 $58.32 $53.38 $46.49 $48.26 $42.39 $40.17 $69.70 $57.74
Cash Flow / Share 12-point trend, -84.3% $1.20 $3.18 $3.65 $5.38 $5.96 $7.55 $5.55 $6.17 $5.01 $5.47 $8.46 $7.68
Cash / Share 12-point trend, -1.5% $8.66 $9.53 $17.27 $15.02 $12.37 $14.83 $10.84 $9.09 $10.29 $7.18 $11.47 $8.80
EPS (TTM) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
معدلات النمو 9
بيانات معدلات النمو السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +81.2% 8.3% -7.2% -7.8% -15.8% 4.6% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +62.6% -2.5% -10.4% -6.7% · · · · · · · · ·
Revenue CAGR 5Y -4.0% · · · · · · · · · · ·
EPS YoY 5-point trend, -3211.7% -73.5% -33.6% -8.1% -37.4% -2.2% · · · · · · ·
EPS CAGR 3Y 3-point trend, -161.4% -45.5% -27.4% -17.4% · · · · · · · · ·
EPS CAGR 5Y -37.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -1037.6% -74.4% -34.1% -8.0% -40.5% -6.5% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -131.1% -46.3% -28.8% -20.0% · · · · · · · · ·
Net Income CAGR 5Y -38.7% · · · · · · · · · · ·
التقييم (آخر 12 شهرًا) 10
بيانات التقييم (آخر 12 شهرًا) السنوية لـ USNA
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Net Income TTM 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
Market Cap 12-point trend, -45.0% $355M $680M $1.03B $1.02B $1.96B $1.62B $1.73B $2.71B $1.78B $1.50B $798M $646M
P/E 12-point trend, +83.5% 33.5 16.3 16.2 14.8 17.7 13.2 18.1 22.5 29.3 15.3 17.8 18.3
P/S 12-point trend, -53.0% 0.4 0.8 1.1 1.0 1.7 1.4 1.6 2.3 1.7 1.5 0.9 0.8
P/B 12-point trend, -76.3% 0.7 1.3 2.1 2.4 5.0 3.7 4.9 6.9 4.9 4.6 2.8 2.8
P / Tangible Book 6-point trend, -67.1% 1.4 2.9 2.3 2.7 5.7 4.1 · · · · · ·
P / Cash Flow 12-point trend, +158.9% 15.9 11.2 14.5 9.8 16.2 10.1 13.7 17.8 14.4 10.9 7.2 6.1
P / FCF 12-point trend, +446.9% 41.7 13.4 18.3 10.9 18.1 11.2 15.7 19.3 16.1 14.4 9.1 7.6
Earnings Yield 12-point trend, -45.6% 3.0% 6.1% 6.2% 6.8% 5.7% 7.6% 5.5% 4.5% 3.4% 6.5% 5.6% 5.5%

القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات

قائمة الدخل
2026-01-032024-12-282023-12-302022-12-312022-01-01
الإيرادات $925M$855M$921M$999M$1.19B
هامش الربح الإجمالي % 78.3%81.1%80.8%80.6%81.6%
هامش الربح التشغيلي % 4.0%7.8%10.1%10.8%14.3%
صافي الدخل $11M$42M$64M$69M$117M
EPS المخفف $0.58$2.19$3.30$3.59$5.73
الميزانية العمومية
2026-01-032024-12-282023-12-302022-12-312022-01-01
النسبة الحالية 2.22.03.52.72.3
النسبة السريعة 1.21.32.82.01.5
التدفق النقدي
2026-01-032024-12-282023-12-302022-12-312022-01-01
التدفق النقدي الحر $9M$51M$56M$94M$108M

مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة

📊

اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.

يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.

الملاك المؤسسيون (13F) 153 مقدمي إقرار · $177.1M إجمالي · حتى تاريخ 30 يونيو، 2026

المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.

النشاط المؤسسي — Q2 2026 مقابل الربع السابق
مراكز جديدة المراكز الخارجة زيادة انخفض صافي التغير في الأسهم
30 (0 مقابل الربع السابق) 17 (+8 مقابل الربع السابق) 48 (+3 مقابل الربع السابق) 34 (-7 مقابل الربع السابق) +96K

مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.

مؤسسة القيمة الأسهم % من 13F المتتبعة النوع
PZENA INVESTMENT MANAGEMENT LLC $25739282 1205587 14,54% الأسهم
RENAISSANCE TECHNOLOGIES LLC $20464402 958520 11,56% الأسهم
Nantahala Capital Management, LLC $17295080 810074 9,77% الأسهم
DIMENSIONAL FUND ADVISORS LP $16958134 794292 9,58% الأسهم
VANGUARD CAPITAL MANAGEMENT LLC $10405350 487370 5,88% الأسهم
VANGUARD PORTFOLIO MANAGEMENT LLC $7758099 363377 4,38% الأسهم
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5811641 272208 3,28% الأسهم
STATE STREET CORP $5577474 261240 3,15% الأسهم
GEODE CAPITAL MANAGEMENT, LLC $5175448 242342 2,92% الأسهم
AMERICAN CENTURY COMPANIES INC $3999880 187348 2,26% الأسهم
JACOBS LEVY EQUITY MANAGEMENT, INC $3855105 180567 2,18% الأسهم
TWO SIGMA INVESTMENTS, LP $3533724 165514 2,00% الأسهم
D. E. Shaw & Co., Inc. $3348427 156835 1,89% الأسهم
Allianz Asset Management GmbH $3040219 142399 1,72% الأسهم
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2949567 138153 1,67% الأسهم
ALGERT GLOBAL LLC $2813033 131758 1,59% الأسهم
UBS Group AG $2474166 115886 1,40% الأسهم
BlackRock, Inc. $2353005 110211 1,33% الأسهم
LAZARD ASSET MANAGEMENT LLC $2077590 97311 1,17% الأسهم
VANGUARD FIDUCIARY TRUST CO $1549540 72578 0,88% الأسهم
Vanguard Global Advisers, LLC $1514569 70940 0,86% الأسهم
Empowered Funds, LLC $1499902 70253 0,85% الأسهم
AMERIPRISE FINANCIAL INC $1443624 67617 0,82% الأسهم
TWO SIGMA ADVISERS, LP $1289691 65700 0,73% الأسهم
GOLDMAN SACHS GROUP INC $1121921 52549 0,63% الأسهم
Quantinno Capital Management LP $1072261 50223 0,61% الأسهم
BANK OF AMERICA CORP /DE/ $967539 45318 0,55% الأسهم
ROYCE & ASSOCIATES LP $884039 41407 0,50% الأسهم
DEUTSCHE BANK AG\ $821975 38500 0,46% الأسهم
Assenagon Asset Management S.A. $815848 38213 0,46% الأسهم
BARCLAYS PLC $769220 36029 0,43% الأسهم
STRS OHIO $723765 33900 0,41% الأسهم
Skopos Labs, Inc. $673696 38563 0,38% الأسهم
HSBC HOLDINGS PLC $672758 31960 0,38% الأسهم
Bank of New York Mellon Corp $668447 31309 0,38% الأسهم
XTX Topco Ltd $625320 29289 0,35% الأسهم
MILLENNIUM MANAGEMENT LLC $570728 26732 0,32% الأسهم
CITADEL ADVISORS LLC $569639 26681 0,32% الأسهم
Verdad Advisers, LP $556552 26068 0,31% الأسهم
Inspire Investing, LLC $512954 29362 0,29% الأسهم
Sanctuary Advisors, LLC $497113 23284 0,28% الأسهم
Man Group plc $489854 22944 0,28% الأسهم
State of Tennessee, Department of Treasury $461160 21600 0,26% الأسهم
Point72 Asset Management, L.P. $397238 18606 0,22% الأسهم
Unison Advisors LLC $384300 18000 0,22% الأسهم
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $384215 17996 0,22% الأسهم
Numerai GP LLC $382080 17896 0,22% الأسهم
KLP KAPITALFORVALTNING AS $375760 17600 0,21% الأسهم
Connor, Clark & Lunn Investment Management Ltd. $366836 17182 0,21% الأسهم
ALLIANCEBERNSTEIN L.P. $357611 20470 0,20% الأسهم
CITADEL ADVISORS LLC $356545 16700 0,20% عقد خيار البيع
Park Capital Management, LLC / WI $345144 16166 0,19% الأسهم
Engineers Gate Manager LP $337672 15816 0,19% الأسهم
SEGALL BRYANT & HAMILL, LLC $318414 14914 0,18% الأسهم
RHUMBLINE ADVISERS $309778 14510 0,17% الأسهم
Vanguard Personalized Indexing Management, LLC $309724 14507 0,17% الأسهم
FIRST TRUST ADVISORS LP $308998 14473 0,17% الأسهم
Toroso Investments, LLC $304756 15525 0,17% الأسهم
EXCHANGE TRADED CONCEPTS, LLC $300992 14098 0,17% الأسهم
IEQ CAPITAL, LLC $300245 14063 0,17% الأسهم
Y-Intercept (Hong Kong) Ltd $298366 13975 0,17% الأسهم
Focus Partners Wealth $292794 13714 0,17% الأسهم
CITADEL ADVISORS LLC $273280 12800 0,15% عقد خيار الشراء
BNP PARIBAS FINANCIAL MARKETS $263160 12326 0,15% الأسهم
MERCER GLOBAL ADVISORS INC /ADV $243881 11423 0,14% الأسهم
State of Wyoming $242237 11346 0,14% الأسهم
ANCHYRA PARTNERS LLC $230238 10784 0,13% الأسهم
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $229982 10772 0,13% الأسهم
OCCUDO QUANTITATIVE STRATEGIES LP $226652 10616 0,13% الأسهم
Mariner, LLC $219915 10302 0,12% الأسهم
DGS Capital Management, LLC $207876 11899 0,12% الأسهم
Cerity Partners LLC $141913 6647 0,08% الأسهم
Magnetar Financial LLC $138540 6489 0,08% الأسهم
MetLife Investment Management, LLC $124236 5819 0,07% الأسهم
Russell Investments Group, Ltd. $123637 5791 0,07% الأسهم
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $109931 5149 0,06% الأسهم
Creative Planning $107156 5019 0,06% الأسهم
FMR LLC $105661 4949 0,06% الأسهم
SIGNATUREFD, LLC $101391 4749 0,06% الأسهم
CWM, LLC $97413 5576 0,06% الأسهم
VANGUARD GROUP INC $96226 4902 0,05% الأسهم
Invesco Ltd. $95072 4453 0,05% الأسهم
NEW YORK STATE COMMON RETIREMENT FUND $81045 3796 0,05% الأسهم
Police & Firemen's Retirement System of New Jersey $73935 3463 0,04% الأسهم
Parallel Advisors, LLC $70818 3317 0,04% الأسهم
Farther Finance Advisors, LLC $41873 1964 0,02% الأسهم
Arax Advisory Partners $40588 1901 0,02% الأسهم
NATIONAL BANK OF CANADA /FI/ $40499 1896 0,02% الأسهم
AlphaQuest LLC $38259 1949 0,02% الأسهم
NORTHERN TRUST CORP $37533 1758 0,02% الأسهم
OSAIC HOLDINGS, INC. $34383 1611 0,02% الأسهم
LOM Asset Management Ltd $34160 1600 0,02% الأسهم
Versant Capital Management, Inc $33904 1588 0,02% الأسهم
MORGAN STANLEY $31363 1469 0,02% الأسهم
Ameritas Investment Partners, Inc. $23933 1121 0,01% الأسهم
Tower Research Capital LLC (TRC) $22909 1073 0,01% الأسهم
Legal & General Group Plc $20966 982 0,01% الأسهم
Integrated Wealth Concepts LLC $18833 882 0,01% الأسهم
CITIGROUP INC $17635 826 0,01% الأسهم
Global Retirement Partners, LLC $14433 676 0,01% الأسهم

المطلعون على الشركة 38 من المطلعين · مسؤولون 20 · مديرون 13

مطلع الدور آخر نشاط الأسهم المملوكة مشتريات 12 شهرًا مبيعات 12 شهرًا صافي 12 شهرًا
Jim Brown CEO & PRESIDENT 24 يوليو، 2025 M 16934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 27 مايو، 2026 S 0 0 1 $-100500
Jeffrey Yates Chief Financial Officer 28 أكتوبر، 2010 M 0 0 0 $0
Deborah Woo President of Asia 8 سبتمبر، 2016 M 1479 0 0 $0
Fred W Cooper President and COO 28 أكتوبر، 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 19 فبراير، 2026 A 0 0 0 $0
Roy Truett Chief Operating Officer 27 يوليو، 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 25 يوليو، 2026 M 3471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 25 يوليو، 2026 M 422 0 0 $0
Brent Neidig CHIEF COMMERCIAL OFFICER 16 يونيو، 2026 S 0 0 3 $-147749
Paul A. Jones CHIEF PEOPLE OFFICER 8 يونيو، 2026 S 0 0 1 $-102878
David Mulham Mulham CHIEF SALES OFFICER 30 يوليو، 2025 S 9260 0 0 $0
Joshua Foukas CHIEF LEGAL OFFICER 12 مارس، 2025 S 0 0 0 $0
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 2 مايو، 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 5 مارس، 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 5 فبراير، 2018 A 2076 0 0 $0
Dave Wentz Co-C.E.O. 16 أغسطس، 2016 M 384883 0 0 $0
Rick Stambaugh Chief Information Officer 17 ديسمبر، 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 28 أكتوبر، 2010 M 5000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 25 فبراير، 2008 S 0 0 0 $0
Xia Ding مدير 23 يوليو، 2026 M 8278 0 0 $0
John Turman Fleming مدير 23 يوليو، 2026 M 5862 0 1 $-43928
Peggie Pelosi مدير 23 يوليو، 2026 M 6061 0 0 $0
Scott J Nixon مدير 23 يوليو، 2026 M 11445 0 0 $0
Frederic J Winssinger مدير 23 يوليو، 2026 M 9733 0 0 $0
Timothy E Wood مدير 23 يوليو، 2026 M 11837 0 0 $0
Gilbert A Fuller مدير 23 يوليو، 2026 M 1632 0 3 $-60414
Robert Auciaux مدير 9 فبراير، 2022 M 436 0 0 $0
Feng Peng مدير 28 إبريل، 2021 M 755 0 0 $0
Myron W. Wentz مدير 4 فبراير، 2019 S 9865614 0 0 $0
Jerry G Mcclain مدير 4 مارس، 2016 M 0 0 0 $0
Ronald S Poelman مدير 8 فبراير، 2016 A 0 0 0 $0
Denis E Waitley مدير 3 نوفمبر، 2006 M 0 0 0 $0
Gull Global Limited مالك 10% 4 فبراير، 2019 S 9865614 0 0 $0
GULL HOLDINGS LTD مالك 10% 1 إبريل، 2015 J 6491110 0 0 $0
Kevin Guest 27 فبراير، 2026 M 45381 0 0 $0
Donald R. Williams 1 مايو، 2017 A 0 0 $0
Doug Braun 16 ديسمبر، 2015 M 0 0 0 $0

المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط

الناشطون والمالكون بنسبة 5%+ 3 حيازات

المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.

مقدم مقدم حصة الحالة الغرض إيداع
Gull Global Limited, Myron W. Wentz ×11 إيداعات 30 مارس، 2026 40,10% تعديل اندماج واستحواذ / بيع SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 23 مايو، 2008 إيداع أولي SEC
Paul & Jane Meyer Family Foundation 20 مايو، 2008 إيداع أولي استثمار سلبي SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 38 صناديق مؤشرات متداولة

الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.

صندوق الوزن الوحدات حتى تاريخ المصدر
DEEP · ETF Series Solutions 0,95% 13646 NS 31 مايو، 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0,25% 13206 NS 31 مايو، 2026 N-PORT
EBIT · Harbor ETF Trust 0,06% 387 NS 30 إبريل، 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,03% 169505 NS 31 مايو، 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,03% 15259 NS 31 مايو، 2026 N-PORT
DFSV · Dimensional ETF Trust 0,02% 87994 NS 30 إبريل، 2026 N-PORT
DFAT · Dimensional ETF Trust 0,01% 97080 NS 30 إبريل، 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,01% 18642 NS 31 مايو، 2026 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0,01% 159569 NS 31 مايو، 2026 N-PORT
DFAS · Dimensional ETF Trust 0,01% 60807 NS 30 إبريل، 2026 N-PORT
RSSL · Global X Funds 0,01% 4685 NS 30 إبريل، 2026 N-PORT
ITWO · ProShares Trust 0,01% 508 NS 31 مايو، 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,00% 51773 NS 31 مايو، 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,00% 2158 NS 31 مايو، 2026 N-PORT
UWM · ProShares Trust 0,00% 397 NS 31 مايو، 2026 N-PORT
URTY · ProShares Trust 0,00% 406 NS 31 مايو، 2026 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0,00% 247 NS 31 مايو، 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 388 NS 31 مايو، 2026 N-PORT
HDG · ProShares Trust 0,00% 10 NS 31 مايو، 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 5468 NS 31 مايو، 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 19278 NS 30 إبريل، 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 6500 NS 31 مايو، 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 1784 NS 30 إبريل، 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 15 يوليو، 2026 يومي
VTI · VANGUARD INDEX FUNDS 15 يوليو، 2026 يومي
VFVA · VANGUARD WELLINGTON FUND 30 يوليو، 2026 يومي
VTWO · VANGUARD SCOTTSDALE FUNDS 15 يوليو، 2026 يومي
VTWV · VANGUARD SCOTTSDALE FUNDS 15 يوليو، 2026 يومي
VTHR · VANGUARD SCOTTSDALE FUNDS 15 يوليو، 2026 يومي
ITOT · iShares Trust 22 يوليو، 2026 يومي
IWV · iShares Trust 18 أغسطس، 2026 يومي
IWN · iShares Trust 17 أغسطس، 2026 يومي
IWM · iShares Trust 18 أغسطس، 2026 يومي
IWC · iShares Trust 18 أغسطس، 2026 يومي
PRFZ · Invesco Exchange-Traded Fund Trust 13 يوليو، 2026 يومي
OMFS · Invesco Exchange-Traded Self-Indexe… 13 يوليو، 2026 يومي
VDC · VANGUARD WORLD FUND 20 يوليو، 2026 يومي
SMLF · iShares Trust 10 أغسطس، 2026 يومي